Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (20202025): What the IP and Science Signal Next This article was powered by Cypris Q, an AI agent that helps R&D teams instantly synthesize insights from patents, scientific literature, and market intelligence from around the globe
Oily fish and omega-3 Omega-3 fatty acids from oily fish like salmon, mackerel, sardines, and herring have modest blood-pressure-lowering effects
While four injectable GLP-1 receptor agonists have already secured regulatory approval, the market is hungry for more convenient oral alternatives
This unique suppository combines the bodys primary antioxidant, 250mg ofglutathione, with the brains primary antioxidant, 200mg of melatonin, alongside the proprietary SandMan Complex to support neurotransmitter balance particularly GABA, the nervous systems primary calming pathway